Pyrido-, pyrimido-, pyridazo- and pyrazo- pyridazines having angiogenesis inhibiting activity
    3.
    发明授权
    Pyrido-, pyrimido-, pyridazo- and pyrazo- pyridazines having angiogenesis inhibiting activity 失效
    具有血管生成抑制活性的吡啶 - ,嘧啶并 - 哒嗪 - 和吡唑并 - 哒嗪

    公开(公告)号:US06514974B2

    公开(公告)日:2003-02-04

    申请号:US09859858

    申请日:2001-05-17

    IPC分类号: A61K3150

    摘要: The invention relates to compounds of formula I, wherein r is 0 to 2, n is 0 to 2; m is 0 to 4; R1 and R2 (i) are in each case a lower alkyl, or (ii) together form a bridge in subformula I* or (iii) together form a bridge in subformula I** wherein one or two of the ring members T1, T2, T3, and T4 are nitrogen, and the remainder are in each case CH; A, B, D, and E are N or CH, wherein not more than 2 of these radicals are N; G is lower alkylene, acyloxy- or hydroxy-lower alkylene, —CH2—O—, —CH2—S—, —CH2—NH—, oxa, thia, or imino; Q is methyl; R is H or lower alkyl; X is imino, oxa, or thia; Y is aryl, pyridyl, or (un)substituted cycloalkyl; and Z is mono- or disubstited amino, halogen, alkyl, substituted alkyl, hydroxy, etherified or esterified hydroxy, nitro, cyano, carboxy, esterified carboxy, alkanoyl, carbamoyl, N-mono- or N,N-disubstituted carbamoyl, amidino, guanidino, mercapto, sulfo, phenylthio, phenyl-lower alkylthio, alkylphenylthio, phenylsulfinyl, phenyl-lower alkylsulfinyl, alkylphenylsulfinyl, phenylsulfonyl, phenyl-lower alkylsulfonyl, or alkylphenylsulfony; and wherein the bonds characterized by a wavy line are either single or double bonds; or an N-oxide of said compound with the stipulation that, if Y is pyridyl or unsubstituted cycloalkyl, X is imino, and the remaining radicals are as defined, then G is selected from the group comprising lower alkylene, —CH2—O—, —CH2—S—, oxa and thia; or a salt thereof. The compounds inhibit angiogenesis.

    摘要翻译: 本发明涉及式I化合物,其中r为0至2,n为0至2; m为0〜4; R1和R2(i)在每种情况下都是低级烷基,或(ii)一起在子式I *中形成桥,或(iii)一起形成子式I **中的桥,其中一个或两个环成员T1,T2 ,T3和T4是氮,余数分别为CH; A,B,D和E是N或CH,其中不多于2个这些基团是N; G是低级亚烷基,酰氧基或羟基 - 低级亚烷基,-CH 2 -O-,-CH 2 -S-,-CH 2 -NH-,氧杂,硫杂或亚氨基; Q是甲基; R为H或低级烷基; X是亚氨基,氧杂或硫杂; Y是芳基,吡啶基或(未)取代的环烷基; 羟基,醚化或酯化的羟基,硝基,氰基,羧基,酯化的羧基,烷酰基,氨基甲酰基,N-单或N,N-二取代的氨基甲酰基,脒基, 胍基,巯基,磺基,苯硫基,苯基 - 低级烷硫基,烷基苯硫基,苯基亚磺酰基,苯基 - 低级烷基亚磺酰基,烷基苯基亚磺酰基,苯基磺酰基,苯基 - 低级烷基磺酰基或烷基苯基磺酰基。 并且其中以波浪线表征的键是单键或双键; 或所述化合物的N-氧化物,其规定如果Y是吡啶基或未取代的环烷基,则X是亚氨基,剩余的基团如所定义,则G选自低级亚烷基,-CH 2 -O-, -CH 2 -S-,氧杂和硫杂; 或其盐。 该化合物抑制血管发生。

    Phthalazines with angiogenesis inhibiting activity
    5.
    发明授权
    Phthalazines with angiogenesis inhibiting activity 失效
    具有血管生成抑制活性的酞嗪类

    公开(公告)号:US06710047B2

    公开(公告)日:2004-03-23

    申请号:US10338062

    申请日:2003-01-07

    IPC分类号: A61K31495

    摘要: The invention relates to compounds of formula I, wherein r is 0 to 2, n is 0 to 2; m is 0 to 4; R1 and R2 (i) are in each case a lower alkyl, or (ii) together form a bridge in subformula I* or (iii) together form a bridge in subformula I** wherein one or two of the ring members T1, T2, T3, and T4 are nitrogen, and the remainder are in each case CH; A, B, D, and E are N or CH, wherein not more than 2 of these radicals are N; G is lower alkylene, acyloxy- or hydroxy-lower alkylene, —CH2—O—, —CH2—S—, —CH2—NH—, oxa, thia, or imino; Q is methyl; R is H or lower alkyl; X is imino, oxa, or thia; Y is aryl, pyridyl, or (un)substituted cycloalkyl; and Z is mono- or disubstited amino, halogen, alkyl, substituted alkyl, hydroxy, etheritied or esterified hydroxy, nitro, cyano, carboxy, esterified carboxy, alkanoyl, carbamoyl, N-mono- or N,N-disubstituted carbamoyl, amidino, guanidino, mercapto, sulfo, phenylthio, phenyl-lower alkylthio, alkylphenylthio, phenylsulfinyl, phenyl-lower alkylsulfinyl, alkylphenylsulfinyl, phenylsulfonyl, phenyl-lower alkylsulfonyl, or alkylphenylsulfony; and wherein the bonds characterized by a wavy line are either single or double bonds; or an N-oxide of said compound with the stipulation that, if Y is pyridyl or unsubstituted cycloalkyl, X is imino, and the remaining radicals are as defined, then G is selected from the group comprising lower alkylene, —CH2—O—, —CH2—S—, oxa and thia; or a salt thereof. The compounds inhibit angiogenesis.

    摘要翻译: 本发明涉及式I化合物,其中r为0至2,n为0至2; m为0〜4; R1和R2(i)在每种情况下都是低级烷基,或(ii)一起在子式I *中形成桥,或(iii)一起形成子式I **中的桥,其中一个或两个环成员T1,T2 ,T3和T4是氮,余数分别为CH; A,B,D和E是N或CH,其中不多于2个这些基团是N; G是低级亚烷基,酰氧基或羟基 - 低级亚烷基,-CH 2 -O-,-CH 2 -S-,-CH 2 -NH-,氧杂,硫杂或亚氨基; Q是甲基; R是H或低级烷基; X是亚氨基,氧杂或硫杂; Y是芳基,吡啶基或(未)取代的环烷基; 羟基,醚基或酯化的羟基,硝基,氰基,羧基,酯化的羧基,烷酰基,氨基甲酰基,N-单或N,N-二取代的氨基甲酰基,脒基, 胍基,巯基,磺基,苯硫基,苯基 - 低级烷硫基,烷基苯硫基,苯基亚磺酰基,苯基 - 低级烷基亚磺酰基,烷基苯基亚磺酰基,苯基磺酰基,苯基 - 低级烷基磺酰基或烷基苯基磺酰基。 并且其中以波浪线表征的键是单键或双键; 或所述化合物的N-氧化物,其规定如果Y是吡啶基或未取代的环烷基,则X是亚氨基,剩余的基团如所定义,则G选自低级亚烷基,-CH 2 -O-, -CH 2 -S-,氧杂和硫杂; 或其盐。 该化合物抑制血管发生。

    Phthalazines with angiogenesis inhibiting activity
    6.
    发明授权
    Phthalazines with angiogenesis inhibiting activity 有权
    具有血管生成抑制活性的酞嗪类

    公开(公告)号:US06258812B1

    公开(公告)日:2001-07-10

    申请号:US09367273

    申请日:1999-10-20

    IPC分类号: A61K31498

    摘要: The invention relates to compounds of formula I, wherein r is 0 to 2, n is 0 to 2; m is 0 to 4; R1 and R2 (i) are in each case a lower alkyl, or (ii) together form a bridge in subformula I* (I*) or (iii) together form a bridge in subformula I** (I**), wherein one or two of the ring members T1, T2, T3, and T4 are nitrogen, and the remainder are in each case CH; A, B, D, and E are N or CH, wherein not more than 2 of these radicals are N; G is lower alkylene, acyloxy- or hydroxy-lower alkylene, —CH2—O—, —CH2—S—, —CH2—NH—, oxa, thia, or imino; Q is methyl; c is H or lower alkyl; X is imino, oxa, or thia; Y is aryl, pyridyl, or (un)substituted cycloalkyl; and Z is mono- or disubstited amino, halogen, alkyl, substituted alkyl, hydroxy, etherified or esterified hydroxy, nitro, cyano, carboxy, esterified carboxy, alkanoyl, carbamoyl, N-mono- or N,N-disubstituted carbamoyl, amidino, guanidino, mercapto, sulfo, phenylthio, phenyl-lower alkylthio, alkylphenylthio, phenylsulfinyl, phenyl-lower alkylsulfinyl, alkylphenylsulfinyl, phenylsulfonyl, phenyl-lower alkylsulfonyl, or alkylphenylsulfony; and wherein the bonds characterized by a wavy line are either single or double bonds; or an N-oxide of said compound with the stipulation that, if Y is pyridyl or unsubstituted cycloalkyl, X is imino, and the remaining radicals are a s defined, then G is selected from the group comprising lower alkylene, —CH2—O—, CH2—S—, oxa and thia; or a salt thereof. The compounds inhibit angiogenesis.

    摘要翻译: 本发明涉及式I化合物,其中r为0至2,n为0至2; m为0〜4; R1和R2(i)在每种情况下都是低级烷基,或(ii)一起在子式I *(I *)中形成桥,或(iii)一起形成子式I **(I **)中的桥,其中 环成员T1,T2,T3和T4中的一个或两个是氮,余下的都是CH; A,B,D和E是N或CH,其中不多于2个这些基团是N; G是低级亚烷基,酰氧基或羟基 - 低级亚烷基,-CH 2 -O-,-CH 2 -S-,-CH 2 -NH-,氧杂,硫杂或亚氨基; Q是甲基; c是H或低级烷基; X是亚氨基,氧杂或硫杂; Y是芳基,吡啶基或(未)取代的环烷基; 羟基,醚化或酯化的羟基,硝基,氰基,羧基,酯化的羧基,烷酰基,氨基甲酰基,N-单或N,N-二取代的氨基甲酰基,脒基, 胍基,巯基,磺基,苯硫基,苯基 - 低级烷硫基,烷基苯硫基,苯基亚磺酰基,苯基 - 低级烷基亚磺酰基,烷基苯基亚磺酰基,苯基磺酰基,苯基 - 低级烷基磺酰基或烷基苯基磺酰基。 并且其中以波浪线表征的键是单键或双键; 或所述化合物的N-氧化物,其规定如果Y是吡啶基或未取代的环烷基,则X是亚氨基,剩余的基团如所定义,则G选自低级亚烷基,-CH 2 -O-, CH2-S-,氧杂和硫杂; 或其盐。 该化合物抑制血管发生。